Detecting the Recurrence of Gastric Cancer after Curative Resection: Comparison of FDG PET/CT and Contrast-Enhanced Abdominal CT

The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the recurrence of gastric cancer. We performed a retrospective review of 139 consecutive patients who underwent PET/CT and contrast-enhanced abdominal...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 26; no. 7; pp. 875 - 880
Main Authors Kim, Dae-Weung, Park, Soon-Ah, Kim, Chang Guhn
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.07.2011
대한의학회
Subjects
Online AccessGet full text
ISSN1011-8934
1598-6357
1598-6357
DOI10.3346/jkms.2011.26.7.875

Cover

Abstract The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the recurrence of gastric cancer. We performed a retrospective review of 139 consecutive patients who underwent PET/CT and contrast-enhanced abdominal CT (CECT) for surveillance of gastric cancer after curative resection. Recurrence of gastric cancer was validated by histopathologic examination for local recurrence or serial imaging study follow-up with at least 1 yr interval for recurrence of distant metastasis form. Twenty-eight patients (20.1%) were confirmed as recurrence. On the patient based analysis, there was no statistically significant difference in the sensitivity, specificity and accuracy of PET/CT (53.6%, 84.7%, and 78.4%, respectively) and those of CECT (64.3%, 86.5%, and 82.0%, respectively) for detecting tumor recurrence except in detection of peritoneal carcinomatosis. Among 36 recurrent lesions, 8 lesions (22.2%) were detected only on PET/CT, and 10 lesions (27.8%) only on CECT. PET/CT had detected secondary malignancy in 8 patients. PET/CT is as accurate as CECT in detection of gastric cancer recurrence after curative resection, excepting detection of peritoneal carcinomatosis. Moreover, additional PET/CT on CECT could improve detection rate of tumor recurrence and provide other critical information such as unexpected secondary malignancy.
AbstractList The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the recurrence of gastric cancer. We performed a retrospective review of 139 consecutive patients who underwent PET/CT and contrast-enhanced abdominal CT (CECT) for surveillance of gastric cancer after curative resection. Recurrence of gastric cancer was validated by histopathologic examination for local recurrence or serial imaging study follow-up with at least 1 yr interval for recurrence of distant metastasis form. Twenty-eight patients (20.1%) were confirmed as recurrence. On the patient based analysis, there was no statistically significant difference in the sensitivity, specificity and accuracy of PET/CT (53.6%, 84.7%, and 78.4%, respectively) and those of CECT (64.3%, 86.5%, and 82.0%, respectively) for detecting tumor recurrence except in detection of peritoneal carcinomatosis. Among 36 recurrent lesions, 8 lesions (22.2%) were detected only on PET/CT, and 10 lesions (27.8%) only on CECT. PET/CT had detected secondary malignancy in 8 patients. PET/CT is as accurate as CECT in detection of gastric cancer recurrence after curative resection, excepting detection of peritoneal carcinomatosis. Moreover, additional PET/CT on CECT could improve detection rate of tumor recurrence and provide other critical information such as unexpected secondary malignancy.
The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the recurrence of gastric cancer. We performed a retrospective review of 139 consecutive patients who underwent PET/CT and contrast-enhanced abdominal CT (CECT) for surveillance of gastric cancer after curative resection. Recurrence of gastric cancer was validated by histopathologic examination for local recurrence or serial imaging study follow-up with at least 1 yr interval for recurrence of distant metastasis form. Twenty-eight patients (20.1%) were confirmed as recurrence. On the patient based analysis, there was no statistically significant difference in the sensitivity, specificity and accuracy of PET/CT (53.6%, 84.7%, and 78.4%, respectively) and those of CECT (64.3%, 86.5%, and 82.0%, respectively) for detecting tumor recurrence except in detection of peritoneal carcinomatosis. Among 36 recurrent lesions, 8 lesions (22.2%) were detected only on PET/CT, and 10 lesions (27.8%) only on CECT. PET/CT had detected secondary malignancy in 8 patients. PET/CT is as accurate as CECT in detection of gastric cancer recurrence after curative resection, excepting detection of peritoneal carcinomatosis. Moreover, additional PET/CT on CECT could improve detection rate of tumor recurrence and provide other critical information such as unexpected secondary malignancy.The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the recurrence of gastric cancer. We performed a retrospective review of 139 consecutive patients who underwent PET/CT and contrast-enhanced abdominal CT (CECT) for surveillance of gastric cancer after curative resection. Recurrence of gastric cancer was validated by histopathologic examination for local recurrence or serial imaging study follow-up with at least 1 yr interval for recurrence of distant metastasis form. Twenty-eight patients (20.1%) were confirmed as recurrence. On the patient based analysis, there was no statistically significant difference in the sensitivity, specificity and accuracy of PET/CT (53.6%, 84.7%, and 78.4%, respectively) and those of CECT (64.3%, 86.5%, and 82.0%, respectively) for detecting tumor recurrence except in detection of peritoneal carcinomatosis. Among 36 recurrent lesions, 8 lesions (22.2%) were detected only on PET/CT, and 10 lesions (27.8%) only on CECT. PET/CT had detected secondary malignancy in 8 patients. PET/CT is as accurate as CECT in detection of gastric cancer recurrence after curative resection, excepting detection of peritoneal carcinomatosis. Moreover, additional PET/CT on CECT could improve detection rate of tumor recurrence and provide other critical information such as unexpected secondary malignancy.
The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the recurrence of gastric cancer. We performed a retrospective review of 139 consecutive patients who underwent PET/CT and contrast-enhanced abdominal CT (CECT) for surveillance of gastric cancer after curative resection. Recurrence of gastric cancer was validated by histopathologic examination for local recurrence or serial imaging study follow-up with at least 1 yr interval for recurrence of distant metastasis form. Twenty-eight patients (20.1%)were confirmed as recurrence. On the patient based analysis, there was no statistically significant difference in the sensitivity, specificity and accuracy of PET/CT (53.6%, 84.7%,and 78.4%, respectively) and those of CECT (64.3%, 86.5%, and 82.0%, respectively) for detecting tumor recurrence except in detection of peritoneal carcinomatosis. Among 36recurrent lesions, 8 lesions (22.2%) were detected only on PET/CT, and 10 lesions (27.8%)only on CECT. PET/CT had detected secondary malignancy in 8 patients. PET/CT is as accurate as CECT in detection of gastric cancer recurrence after curative resection,excepting detection of peritoneal carcinomatosis. Moreover, additional PET/CT on CECT could improve detection rate of tumor recurrence and provide other critical information such as unexpected secondary malignancy. KCI Citation Count: 14
Author Kim, Dae-Weung
Park, Soon-Ah
Kim, Chang Guhn
AuthorAffiliation Department of Nuclear Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
AuthorAffiliation_xml – name: Department of Nuclear Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
Author_xml – sequence: 1
  givenname: Dae-Weung
  surname: Kim
  fullname: Kim, Dae-Weung
  organization: Department of Nuclear Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 2
  givenname: Soon-Ah
  surname: Park
  fullname: Park, Soon-Ah
  organization: Department of Nuclear Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
– sequence: 3
  givenname: Chang Guhn
  surname: Kim
  fullname: Kim, Chang Guhn
  organization: Department of Nuclear Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21738339$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001566986$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kk1v3CAQhq0qVfPR_oEeKm7txY4Nxtg9VFo5m02kSK0i94wwHmfJ2rAFHKm3_vRCNonaHnoBxLzvMwMzp8mRNhqS5H2RZ4SU1fn9bnYZzosiw1XGsprRV8lJQZs6rQhlR-EcYmndkPI4OXXuPs8xpZi8SY5xwUhNSHOS_LoAD9IrfYf8FtAtyMVa0BKQGdFGOG-VRK0IFxaJ0Ye1Xazw6iFqXXQa_Rm1Zt4Lq5zR0XZ5sUHf1t152yGhhxDU3gZSutbbCBrQqh_MrLSYUNu9TV6PYnLw7mk_S75frrv2Kr35urluVzepLEnpUykagL7EuWj6HkaohwZEeI4kFPp8YE1NpWSYyqLs66onuB4kY0P4AYorBpScJZ8OXG1HvpOKG6Ee9zvDd5avbrtrThmpKhakXw7S_dLPMEiI9U98b9Us7M9H498RrbYB88BJgUtWVAHw8QlgzY8FnOezchKmSWgwi-OhUwyTosFB-eHPVC85nhsUBPggkNY4Z2F8kRQ5j1PA4xTwOAUcV5xFdjDV_5ik8iK2KpSrpv9ZfwP96bm0
CitedBy_id crossref_primary_10_18632_oncotarget_21288
crossref_primary_10_3748_wjg_v23_i19_3379
crossref_primary_10_1097_RLU_0b013e318299609f
crossref_primary_10_12701_jyms_2023_00220
crossref_primary_10_1259_imaging_73678953
crossref_primary_10_1371_journal_pone_0130472
crossref_primary_10_1007_s12149_016_1058_y
crossref_primary_10_1007_s13139_012_0169_1
crossref_primary_10_7704_kjhugr_2013_13_4_224
crossref_primary_10_1053_j_ro_2014_07_003
crossref_primary_10_2967_jnumed_112_105049
crossref_primary_10_5230_jgc_2025_25_e11
crossref_primary_10_1016_j_cpet_2017_05_004
crossref_primary_10_1016_j_cpet_2014_07_001
crossref_primary_10_1007_s13277_014_2516_6
crossref_primary_10_1097_MNM_0000000000001481
crossref_primary_10_1016_j_acra_2018_07_020
crossref_primary_10_1007_s12149_014_0871_4
crossref_primary_10_2967_jnumed_115_163295
crossref_primary_10_4240_wjgs_v16_i8_2511
crossref_primary_10_1016_j_suc_2016_11_007
crossref_primary_10_1038_s41467_024_44946_4
crossref_primary_10_1007_s00432_023_05346_1
crossref_primary_10_1007_s00261_015_0418_8
crossref_primary_10_3348_jksr_2014_71_2_69
crossref_primary_10_1186_1756_9966_32_76
crossref_primary_10_5230_jgc_2023_23_e11
crossref_primary_10_1016_j_imu_2021_100581
crossref_primary_10_3748_wjg_v23_i35_6448
crossref_primary_10_1007_s00259_015_3249_5
crossref_primary_10_1016_j_suronc_2013_05_001
crossref_primary_10_4240_wjgs_v15_i10_2280
crossref_primary_10_1007_s00261_016_0647_5
crossref_primary_10_1111_j_1440_1746_2011_06919_x
crossref_primary_10_1007_s00330_021_07839_4
Cites_doi 10.3346/jkms.2010.25.8.1113
10.1007/s00259-001-0743-8
10.1007/s00261-008-9424-4
10.3322/canjclin.57.1.43
10.1007/s12149-007-0015-1
10.3748/wjg.14.4627
10.1007/s00259-005-1887-8
10.1186/1471-2407-9-73
10.1148/radiol.2422051557
10.1007/s00330-008-0979-9
10.1007/s00268-002-6279-7
10.1093/jjco/hyp010
10.1148/rg.245035725
10.1148/radiographics.22.2.g02mr23323
10.1148/rg.261055078
10.2214/ajr.161.5.8273639
10.1007/s002619910003
10.1016/S0009-9260(02)00477-4
10.1016/j.soc.2007.03.003
10.1200/JCO.2004.10.184
ContentType Journal Article
Copyright 2011 The Korean Academy of Medical Sciences. 2011
Copyright_xml – notice: 2011 The Korean Academy of Medical Sciences. 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2011.26.7.875
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 880
ExternalDocumentID oai_kci_go_kr_ARTI_573667
PMC3124716
21738339
10_3346_jkms_2011_26_7_875
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EF.
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
O5R
O5S
OK1
OVT
PGMZT
RNS
RPM
TR2
W2D
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c434t-ca9eeb420a9bbefe8d9ea255c35eb0d7985cc725c14b86b328dc77d1015267e53
IEDL.DBID M48
ISSN 1011-8934
1598-6357
IngestDate Sun Mar 09 07:51:02 EDT 2025
Thu Aug 21 18:45:18 EDT 2025
Thu Jul 10 23:59:40 EDT 2025
Mon Jul 21 05:39:22 EDT 2025
Thu Apr 24 22:51:40 EDT 2025
Tue Jul 01 01:44:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords FDG
Recurrence
Stomach Neoplasms
PET/CT
Contrast-enhanced Abdominal CT
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c434t-ca9eeb420a9bbefe8d9ea255c35eb0d7985cc725c14b86b328dc77d1015267e53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120110260070875
G704-000345.2011.26.7.013
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2011.26.7.875
PMID 21738339
PQID 875723192
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_573667
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3124716
proquest_miscellaneous_875723192
pubmed_primary_21738339
crossref_primary_10_3346_jkms_2011_26_7_875
crossref_citationtrail_10_3346_jkms_2011_26_7_875
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-07-01
PublicationDateYYYYMMDD 2011-07-01
PublicationDate_xml – month: 07
  year: 2011
  text: 2011-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2011
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References Shinya (10.3346/jkms.2011.26.7.875_ref18) 2007; 54
Jung (10.3346/jkms.2011.26.7.875_ref2) 2010; 25
Jensen (10.3346/jkms.2011.26.7.875_ref15) 2007; 16
Sim (10.3346/jkms.2011.26.7.875_ref12) 2009; 9
Yoshioka (10.3346/jkms.2011.26.7.875_ref14) 2003; 44
Sun (10.3346/jkms.2011.26.7.875_ref1) 2008; 14
Kostakoglu (10.3346/jkms.2011.26.7.875_ref22) 2004; 24
Nogami (10.3346/jkms.2011.26.7.875_ref9) 2007; 21
Wu (10.3346/jkms.2011.26.7.875_ref23) 2003; 27
Kim (10.3346/jkms.2011.26.7.875_ref5) 2002; 22
Kitajima (10.3346/jkms.2011.26.7.875_ref8) 2008; 18
Park (10.3346/jkms.2011.26.7.875_ref13) 2009; 34
Kang (10.3346/jkms.2011.26.7.875_ref17) 2000; 25
Jadvar (10.3346/jkms.2011.26.7.875_ref10) 2003; 58
Keidar (10.3346/jkms.2011.26.7.875_ref7) 2004; 45
Jemal (10.3346/jkms.2011.26.7.875_ref3) 2007; 57
Sano (10.3346/jkms.2011.26.7.875_ref4) 2004; 22
De Potter (10.3346/jkms.2011.26.7.875_ref19) 2002; 29
Nakamoto (10.3346/jkms.2011.26.7.875_ref11) 2009; 39
Lim (10.3346/jkms.2011.26.7.875_ref20) 2006; 26
Ha (10.3346/jkms.2011.26.7.875_ref6) 1993; 161
Chen (10.3346/jkms.2011.26.7.875_ref16) 2007; 242
Kim (10.3346/jkms.2011.26.7.875_ref21) 2006; 33
15471827 - J Nucl Med. 2004 Oct;45(10):1640-6
11896222 - Radiographics. 2002 Mar-Apr;22(2):323-36
20676319 - J Korean Med Sci. 2010 Aug;25(8):1113-21
8273639 - AJR Am J Roentgenol. 1993 Nov;161(5):975-7
17581717 - Ann Nucl Med. 2007 Jun;21(4):189-96
18425518 - Eur Radiol. 2008 Oct;18(10):2040-7
16228236 - Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):148-55
10652915 - Abdom Imaging. 2000 Jan-Feb;25(1):14-24
17255419 - Radiology. 2007 Feb;242(2):472-82
16418249 - Radiographics. 2006 Jan-Feb;26(1):143-56
11914891 - Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):525-9
12639527 - Clin Radiol. 2003 Mar;58(3):215-21
15199090 - J Clin Oncol. 2004 Jul 15;22(14):2767-73
19250554 - BMC Cancer. 2009;9:73
19269991 - Jpn J Clin Oncol. 2009 May;39(5):297-302
15371617 - Radiographics. 2004 Sep-Oct;24(5):1411-31
17560516 - Surg Oncol Clin N Am. 2007 Apr;16(2):329-42
18698676 - World J Gastroenterol. 2008 Aug 7;14(29):4627-32
12732669 - J Nucl Med. 2003 May;44(5):690-9
18543017 - Abdom Imaging. 2009 Jul;34(4):441-7
12616428 - World J Surg. 2003 Feb;27(2):153-8
17237035 - CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17708258 - Hepatogastroenterology. 2007 Jul-Aug;54(77):1378-81
References_xml – volume: 25
  start-page: 1113
  year: 2010
  ident: 10.3346/jkms.2011.26.7.875_ref2
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2010.25.8.1113
– volume: 29
  start-page: 525
  year: 2002
  ident: 10.3346/jkms.2011.26.7.875_ref19
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-001-0743-8
– volume: 34
  start-page: 441
  year: 2009
  ident: 10.3346/jkms.2011.26.7.875_ref13
  publication-title: Abdom Imaging
  doi: 10.1007/s00261-008-9424-4
– volume: 57
  start-page: 43
  year: 2007
  ident: 10.3346/jkms.2011.26.7.875_ref3
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.57.1.43
– volume: 21
  start-page: 189
  year: 2007
  ident: 10.3346/jkms.2011.26.7.875_ref9
  publication-title: Ann Nucl Med
  doi: 10.1007/s12149-007-0015-1
– volume: 14
  start-page: 4627
  year: 2008
  ident: 10.3346/jkms.2011.26.7.875_ref1
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.4627
– volume: 45
  start-page: 1640
  year: 2004
  ident: 10.3346/jkms.2011.26.7.875_ref7
  publication-title: J Nucl Med
– volume: 33
  start-page: 148
  year: 2006
  ident: 10.3346/jkms.2011.26.7.875_ref21
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-005-1887-8
– volume: 9
  start-page: 73
  year: 2009
  ident: 10.3346/jkms.2011.26.7.875_ref12
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-73
– volume: 242
  start-page: 472
  year: 2007
  ident: 10.3346/jkms.2011.26.7.875_ref16
  publication-title: Radiology
  doi: 10.1148/radiol.2422051557
– volume: 18
  start-page: 2040
  year: 2008
  ident: 10.3346/jkms.2011.26.7.875_ref8
  publication-title: Eur Radiol
  doi: 10.1007/s00330-008-0979-9
– volume: 27
  start-page: 153
  year: 2003
  ident: 10.3346/jkms.2011.26.7.875_ref23
  publication-title: World J Surg
  doi: 10.1007/s00268-002-6279-7
– volume: 39
  start-page: 297
  year: 2009
  ident: 10.3346/jkms.2011.26.7.875_ref11
  publication-title: Jpn J Clin Oncol
  doi: 10.1093/jjco/hyp010
– volume: 24
  start-page: 1411
  year: 2004
  ident: 10.3346/jkms.2011.26.7.875_ref22
  publication-title: Radiographics
  doi: 10.1148/rg.245035725
– volume: 22
  start-page: 323
  year: 2002
  ident: 10.3346/jkms.2011.26.7.875_ref5
  publication-title: Radiographics
  doi: 10.1148/radiographics.22.2.g02mr23323
– volume: 26
  start-page: 143
  year: 2006
  ident: 10.3346/jkms.2011.26.7.875_ref20
  publication-title: Radiographics
  doi: 10.1148/rg.261055078
– volume: 54
  start-page: 1378
  year: 2007
  ident: 10.3346/jkms.2011.26.7.875_ref18
  publication-title: Hepatogastroenterology
– volume: 161
  start-page: 975
  year: 1993
  ident: 10.3346/jkms.2011.26.7.875_ref6
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.161.5.8273639
– volume: 25
  start-page: 14
  year: 2000
  ident: 10.3346/jkms.2011.26.7.875_ref17
  publication-title: Abdom Imaging
  doi: 10.1007/s002619910003
– volume: 58
  start-page: 215
  year: 2003
  ident: 10.3346/jkms.2011.26.7.875_ref10
  publication-title: Clin Radiol
  doi: 10.1016/S0009-9260(02)00477-4
– volume: 16
  start-page: 329
  year: 2007
  ident: 10.3346/jkms.2011.26.7.875_ref15
  publication-title: Surg Oncol Clin N Am
  doi: 10.1016/j.soc.2007.03.003
– volume: 22
  start-page: 2767
  year: 2004
  ident: 10.3346/jkms.2011.26.7.875_ref4
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.10.184
– volume: 44
  start-page: 690
  year: 2003
  ident: 10.3346/jkms.2011.26.7.875_ref14
  publication-title: J Nucl Med
– reference: 19269991 - Jpn J Clin Oncol. 2009 May;39(5):297-302
– reference: 17560516 - Surg Oncol Clin N Am. 2007 Apr;16(2):329-42
– reference: 18543017 - Abdom Imaging. 2009 Jul;34(4):441-7
– reference: 8273639 - AJR Am J Roentgenol. 1993 Nov;161(5):975-7
– reference: 15471827 - J Nucl Med. 2004 Oct;45(10):1640-6
– reference: 12732669 - J Nucl Med. 2003 May;44(5):690-9
– reference: 10652915 - Abdom Imaging. 2000 Jan-Feb;25(1):14-24
– reference: 19250554 - BMC Cancer. 2009;9:73
– reference: 11896222 - Radiographics. 2002 Mar-Apr;22(2):323-36
– reference: 18698676 - World J Gastroenterol. 2008 Aug 7;14(29):4627-32
– reference: 12639527 - Clin Radiol. 2003 Mar;58(3):215-21
– reference: 17708258 - Hepatogastroenterology. 2007 Jul-Aug;54(77):1378-81
– reference: 20676319 - J Korean Med Sci. 2010 Aug;25(8):1113-21
– reference: 16228236 - Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):148-55
– reference: 15199090 - J Clin Oncol. 2004 Jul 15;22(14):2767-73
– reference: 18425518 - Eur Radiol. 2008 Oct;18(10):2040-7
– reference: 17581717 - Ann Nucl Med. 2007 Jun;21(4):189-96
– reference: 16418249 - Radiographics. 2006 Jan-Feb;26(1):143-56
– reference: 15371617 - Radiographics. 2004 Sep-Oct;24(5):1411-31
– reference: 11914891 - Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):525-9
– reference: 12616428 - World J Surg. 2003 Feb;27(2):153-8
– reference: 17237035 - CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
– reference: 17255419 - Radiology. 2007 Feb;242(2):472-82
SSID ssj0025523
Score 2.103139
Snippet The purpose of this study was to evaluate the value of fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for detecting the...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 875
SubjectTerms Aged
Female
Fluorodeoxyglucose F18
Humans
Male
Middle Aged
Neoplasm Recurrence, Local - diagnosis
Neoplasm Recurrence, Local - diagnostic imaging
Original
Positron-Emission Tomography - methods
Radiopharmaceuticals
Retrospective Studies
Sensitivity and Specificity
Stomach Neoplasms - diagnosis
Stomach Neoplasms - pathology
Stomach Neoplasms - surgery
Tomography, X-Ray Computed - methods
의학일반
Title Detecting the Recurrence of Gastric Cancer after Curative Resection: Comparison of FDG PET/CT and Contrast-Enhanced Abdominal CT
URI https://www.ncbi.nlm.nih.gov/pubmed/21738339
https://www.proquest.com/docview/875723192
https://pubmed.ncbi.nlm.nih.gov/PMC3124716
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001566986
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2011, 26(7), 153, pp.875-880
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pa9swFBZtB2OXst9zuwUNdhvOYlmW7MEYxU3abmSMkUBvQpLltaS1WyeB7bY_fe_JjmlHt8NOPtiSQE_ye5_e0_cR8gagsRbGpmHJ0lHILfwHMyvSkOuSySJyccTxovD0izie80-nyekW2cgddRO4vBPaoZ7UvLkY_rj--RE2_AdEnDFmKBeXy5aMk4mhHEIEvk3ugWcSCMamvM8qQPTM2oL7KArBT_P2Es1f-vA0wRIAHOqI3_BZ21VT3hWO_llVecNNTR6S3S6-pAftgnhEtlz1mNyfdhn0J-TXocO0ATgsCqEf_YbH7f7CH61LeqRRxcPSHJdCQ71-OM3XLTk4xSI9fwviPc179UJsNjk8ol_Hs3f5jOqqoEh41UBP4bg68_UF9MAUtRcPo_nsKZlPxrP8OOxUGELLY74Krc6cM5yNdGaMK11aZE7DVNo4cWZUyCxNrJUssRE3qTAxSwsrwcwQZzAhXRI_IztVXbkXhEaRtc6UqHRWcIvUZ8moiAzXyGHPnAlItJlnZTuKclTKuFAAVdBMCs2k0EyKCSUVmCkgb_s2Vy1Bxz-_fg3mUwt7rpBXG5_fa7VoFKCHE5XIWAgZELoxroK9hgkUXbl6vcQOJMTDGQvI89bW_ZCbpRIQeWsV9B_gcLffVOdnns47hhALUOvef7fcJw_ak24sIn5JdlbN2r2CUGllBgASTj4P_EHDwO-F3xxtE5Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detecting+the+Recurrence+of+Gastric+Cancer+after+Curative+Resection%3A+Comparison+of+FDG+PET%2FCT+and+Contrast-Enhanced+Abdominal+CT&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Kim%2C+Dae-Weung&rft.au=Park%2C+Soon-Ah&rft.au=Kim%2C+Chang+Guhn&rft.date=2011-07-01&rft.pub=The+Korean+Academy+of+Medical+Sciences&rft.issn=1011-8934&rft.eissn=1598-6357&rft.volume=26&rft.issue=7&rft.spage=875&rft.epage=880&rft_id=info:doi/10.3346%2Fjkms.2011.26.7.875&rft_id=info%3Apmid%2F21738339&rft.externalDocID=PMC3124716
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon